BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 1999510)

  • 1. International symposium on cutaneous T cell lymphoma. Chicago, Illinois, Oct. 19-21, 1989.
    Springer EA; Kuzel TM; Rosen ST; Roenigk HH
    J Am Acad Dermatol; 1991 Jan; 24(1):136-8. PubMed ID: 1999510
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cutaneous T-cell lymphoma].
    Dippel E; Gellrich S; Klemke CD; Goerdt S; Sterry W
    J Dtsch Dermatol Ges; 2003 Dec; 1(12):965-80; quiz 981-2. PubMed ID: 16285650
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current therapy concepts in cutaneous T-cell lymphomas].
    Nestle FO; Häffner AC; Schmid MH; Dummer R; Burg G
    Schweiz Med Wochenschr; 1997 Feb; 127(8):311-20. PubMed ID: 9157537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic treatment for cutaneous lymphomas.
    Mielke V; Staib G; Sterry W
    Recent Results Cancer Res; 1995; 139():403-8. PubMed ID: 7597307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous T-cell lymphoma: centuries of controversy.
    Duncan K; Heald P
    Semin Cutan Med Surg; 1998 Jun; 17(2):133-40. PubMed ID: 9669606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy of cutaneous T cell lymphoma with interferon alpha-2a and photochemotherapy.
    Stadler R; Otte HG
    Recent Results Cancer Res; 1995; 139():391-401. PubMed ID: 7597306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings of the Second International Symposium on Cutaneous T-cell Lymphoma. Chicago, Illinois, Oct. 13-17, 1993.
    Herrmann JJ; Kuzel TM; Rosen ST; Roenigk HH
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):819-22. PubMed ID: 7523465
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic alternatives in cutaneous T-cell lymphoma.
    Holloway KB; Flowers FP; Ramos-Caro FA
    J Am Acad Dermatol; 1992 Sep; 27(3):367-78. PubMed ID: 1383293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycosis fungoides palmaris et plantaris--an unusual variant of cutaneous T-cell lymphoma.
    Topf S; Lüftl M; Neisius U; Brabletz T; Simon M; Schuler G; Schultz ES
    Eur J Dermatol; 2006; 16(1):84-6. PubMed ID: 16436350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of local PUVA-therapy and interferon alpha-2A in the treatment of tumoral stage mycosis fungoides.
    Delpuget-Bertin N; Bernard P; Bedane C; Dang PM; Bonnetblanc JM
    Dermatology; 1996; 193(1):74-5. PubMed ID: 8864634
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapy of cutaneous lymphoma--current practice and future developments.
    Dummer R; Kempf W; Hess Schmid M; Häffner A; Burg G
    Onkologie; 2003 Aug; 26(4):366-72. PubMed ID: 12972705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cutaneous lymphomas. Quality Assurance Committee of the German Society of Dermatology and the Professional Organization of German Dermatologists e. V].
    Dummer R
    Hautarzt; 1998 Oct; 48 Suppl 1():S49-55. PubMed ID: 9866049
    [No Abstract]   [Full Text] [Related]  

  • 14. Memorials and mandates for cutaneous lymphomas.
    Heald PW
    Arch Dermatol; 2003 Jul; 139(7):926-8. PubMed ID: 12873891
    [No Abstract]   [Full Text] [Related]  

  • 15. Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma.
    Roenigk HH; Kuzel TM; Skoutelis AP; Springer E; Yu G; Caro W; Gilyon K; Variakojis D; Kaul K; Bunn PA
    J Invest Dermatol; 1990 Dec; 95(6 Suppl):198S-205S. PubMed ID: 2258636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective randomized multicenter clinical trial on the use of interferon -2a plus acitretin versus interferon -2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II.
    Stadler R; Otte HG; Luger T; Henz BM; Kühl P; Zwingers T; Sterry W
    Blood; 1998 Nov; 92(10):3578-81. PubMed ID: 9808550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modern therapy of mycosis fungoides].
    Roenigk HH
    Hautarzt; 1983 Jun; 34(6):266-72. PubMed ID: 6874333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cutaneous lymphomas].
    Schad K; Baumann Conzett K; Cozzio A
    Ther Umsch; 2010 Sep; 67(9):453-64. PubMed ID: 20806174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Juvenile mycosis fungoides with large-cell transformation: Successful treatment with psoralen with ultraviolet A light, interferon-alfa, and localized radiation.
    Chan WH; Lewis DJ; Hinojosa T; Curry JL; Duvic M
    Pediatr Dermatol; 2018 Jan; 35(1):e13-e16. PubMed ID: 29159918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controversies in the management of the cutaneous T cell lymphomas.
    Zic JA
    Dermatol Ther; 2009; 22(5):407-17. PubMed ID: 19845718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.